Tygh Capital Management, Inc. - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.

Quarter-by-quarter ownership
Tygh Capital Management, Inc. ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q4 2021$4,046,000
-0.2%
29,360
+0.6%
0.52%
-5.6%
Q3 2021$4,056,000
+45.0%
29,197
+1.4%
0.55%
+44.1%
Q2 2021$2,797,000
+40.6%
28,808
-1.0%
0.38%
+35.6%
Q1 2021$1,989,000
-17.0%
29,102
+4.1%
0.28%
-24.7%
Q4 2020$2,395,000
+34.9%
27,944
+2.3%
0.37%
+10.7%
Q3 2020$1,776,00027,3250.34%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
UBS OCONNOR LLC 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders